The deal, signed last Tuesday, will also allow Phoenix Life International to market and export its diabetes-treating marijuana drug.
According to a release from Phoenix Life, it will create a national healthcare network in Vanuatu and produce medical cannabis products there.
The network will include community healthcare clinics and drug dispensaries which will provide the company's product.
Under the agreement, Phoenix Life plans to train medical professionals on the use of medical cannabis for treating type 2 diabetes.
